Literature DB >> 36094315

Reovirus Efficiently Reassorts Genome Segments during Coinfection and Superinfection.

Timothy W Thoner1, Madeline M Meloy2, Jacob M Long2, Julia R Diller2, James C Slaughter3, Kristen M Ogden1,2.   

Abstract

Reassortment, or genome segment exchange, increases diversity among viruses with segmented genomes. Previous studies on the limitations of reassortment have largely focused on parental incompatibilities that restrict generation of viable progeny. However, less is known about whether factors intrinsic to virus replication influence reassortment. Mammalian orthoreovirus (reovirus) encapsidates a segmented, double-stranded RNA (dsRNA) genome, replicates within cytoplasmic factories, and is susceptible to host antiviral responses. We sought to elucidate the influence of infection multiplicity, timing, and compartmentalized replication on reovirus reassortment in the absence of parental incompatibilities. We used an established post-PCR genotyping method to quantify reassortment frequency between wild-type and genetically barcoded type 3 reoviruses. Consistent with published findings, we found that reassortment increased with infection multiplicity until reaching a peak of efficient genome segment exchange during simultaneous coinfection. However, reassortment frequency exhibited a substantial decease with increasing time to superinfection, which strongly correlated with viral transcript abundance. We hypothesized that physical sequestration of viral transcripts within distinct virus factories or superinfection exclusion also could influence reassortment frequency during superinfection. Imaging revealed that transcripts from both wild-type and barcoded viruses frequently co-occupied factories, with superinfection time delays up to 16 h. Additionally, primary infection progressively dampened superinfecting virus transcript levels with greater time delay to superinfection. Thus, in the absence of parental incompatibilities and with short times to superinfection, reovirus reassortment proceeds efficiently and is largely unaffected by compartmentalization of replication and superinfection exclusion. However, reassortment may be limited by superinfection exclusion with greater time delays to superinfection. IMPORTANCE Reassortment, or genome segment exchange between viruses, can generate novel virus genotypes and pandemic virus strains. For viruses to reassort their genome segments, they must replicate within the same physical space by coinfecting the same host cell. Even after entry into the host cell, many viruses with segmented genomes synthesize new virus transcripts and assemble and package their genomes within cytoplasmic replication compartments. Additionally, some viruses can interfere with subsequent infection of the same host or cell. However, spatial and temporal influences on reassortment are only beginning to be explored. We found that infection multiplicity and transcript abundance are important drivers of reassortment during coinfection and superinfection, respectively, for reovirus, which has a segmented, double-stranded RNA genome. We also provide evidence that compartmentalization of transcription and packaging is unlikely to influence reassortment, but the length of time between primary and subsequent reovirus infection can alter reassortment frequency.

Entities:  

Keywords:  coinfection; double-stranded RNA virus; reassortment; reovirus; superinfection; superinfection exclusion

Mesh:

Substances:

Year:  2022        PMID: 36094315      PMCID: PMC9517712          DOI: 10.1128/jvi.00910-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  75 in total

1.  5'-Terminal m-7G(5')ppp(5')G-m-p in vivo: identification in reovirus genome RNA.

Authors:  Y Furuichi; S Muthukrishnan; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Superinfecting rotaviruses are not excluded from genetic interactions during asynchronous mixed infections in vitro.

Authors:  R F Ramig
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

3.  Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.

Authors:  Megan T Baldridge; Sanghyun Lee; Judy J Brown; Nicole McAllister; Kelly Urbanek; Terence S Dermody; Timothy J Nice; Herbert W Virgin
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

4.  Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores.

Authors:  J J Skehel; W K Joklik
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

Review 5.  Zoonotic transmission of rotavirus: surveillance and control.

Authors:  Renáta Dóró; Szilvia L Farkas; Vito Martella; Krisztián Bányai
Journal:  Expert Rev Anti Infect Ther       Date:  2015-10-01       Impact factor: 5.091

6.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

7.  Reovirus progeny subviral particles synthesize uncapped mRNA.

Authors:  H Zarbl; D Skup; S Millward
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

8.  Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9.

Authors:  Jennifer Zurney; Takeshi Kobayashi; Geoffrey H Holm; Terence S Dermody; Barbara Sherry
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

Review 9.  Influenza A virus reassortment.

Authors:  John Steel; Anice C Lowen
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

10.  Absence of superinfection exclusion during asynchronous reovirus infections of mouse, monkey, and human cell lines.

Authors:  N D Keirstead; K M Coombs
Journal:  Virus Res       Date:  1998-04       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.